These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7226474)

  • 1. Myocardial metabolic and hemodynamic effects of dobutamine in heart failure complicating coronary artery disease.
    Pozen RG; DiBianco R; Katz RJ; Bortz R; Myerburg RJ; Fletcher RD
    Circulation; 1981 Jun; 63(6):1279-85. PubMed ID: 7226474
    [No Abstract]   [Full Text] [Related]  

  • 2. Dobutamine in chronic ischemic heart failure: alterations in left ventricular function and coronary hemodynamics.
    Bendersky R; Chatterjee K; Parmley WW; Brundage BH; Ports TA
    Am J Cardiol; 1981 Sep; 48(3):554-8. PubMed ID: 7270460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemodynamic effects of dobutamine in the low-output cardiac syndrome].
    Pradella A; Codecà L; De Lorenzi E
    G Ital Cardiol; 1979; 9(7):763-6. PubMed ID: 540708
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of dobutamine on left ventricular performance and myocardial metabolic demands in patients with ischemic heart disease.
    Côté P; Bourassa MG; Tubau JF; Enjalbert M; Vandormael M
    Clin Cardiol; 1984 Jan; 7(1):14-22. PubMed ID: 6705283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer catecholamines for treatment of heart failure and shock: an update on dopamine and a first look at dobutamine.
    Goldberg LI; Hsieh YY; Resnekov L
    Prog Cardiovasc Dis; 1977; 19(4):327-40. PubMed ID: 12536
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemodynamic effect of dobutamine in patients with cardiac insufficiency].
    Delius W; Wirtzfeld A; Sebening H
    Verh Dtsch Ges Kreislaufforsch; 1976; 42():197-200. PubMed ID: 1007566
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemodynamic and cardiac metabolic effects of inotropic stimulation with dobutamine in patients with coronary artery disease.
    Kupper W; Waller D; Hanrath P; Bleifeld W
    Eur Heart J; 1982 Feb; 3(1):29-34. PubMed ID: 7075609
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemodynamic effects of dobutamine in patients with severe low-output heart failure (author's transl)].
    Parodi O; Crea F; Pesola A; Distante A; Chierchia S; Moscarelli E; L'Abbate A; Maseri A
    G Ital Cardiol; 1980; 10(9):1141-7. PubMed ID: 7193152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease.
    Meyer SL; Curry GC; Donsky MS; Twieg DB; Parkey RW; Willerson JT
    Am J Cardiol; 1976 Jul; 38(1):103-8. PubMed ID: 937182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of the action of dobutamine in acute cardiac insufficiency].
    Chevalier P; Leylavergne J; Gournay G; Laffay N; Gryman R; Renault C; Guérot C; Valère PE; Tricot R
    Ann Cardiol Angeiol (Paris); 1984; 33(4):227-32. PubMed ID: 6147116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic effects of dobutamine in patients with coronary artery disease.
    Magnani B; Ambrosioni E; Branzi A; Picchio F; Capitanucci P
    J Int Med Res; 1977; 5(1):10-7. PubMed ID: 838109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New catecholamines in clinical cardiovascular medicine.
    Leier CV
    Kardiol Pol; 1980; 23(9):721-5. PubMed ID: 7441942
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of dobutamine on exercise performance in patients with symptomatic ischemic heart disease.
    Rabinovitch MA; Kalff V; Chan W; Schork A; Gross MD; Vogel RA; Thrall JH; Pitt B
    Am Heart J; 1984 Jan; 107(1):81-5. PubMed ID: 6691244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination of dopamine and dobutamine in the differential therapy of acute and chronic myocardial failure].
    Kleinschmidt R; Spannbrucker N; Vogel F
    Dtsch Med Wochenschr; 1985 Apr; 110(15):598-603. PubMed ID: 2983969
    [No Abstract]   [Full Text] [Related]  

  • 15. [Catecholamines in internal medicine emergencies].
    Brandt D; Pristautz H; Klein W
    Wien Med Wochenschr; 1984 Jul; 134(13-14):324-7. PubMed ID: 6495745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined hemodynamic effects of dobutamine and IV nitroglycerin in congestive heart failure.
    Gagnon RM; Fortin L; Boucher R; Gilbert S; Morrisette M; Present S; Lemire J; David A
    Chest; 1980 Nov; 78(5):694-8. PubMed ID: 6775881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dobutamine and hydralazine: comparative influences of positive inotropy and vasodilation on coronary blood flow and myocardial energetics in nonischemic congestive heart failure.
    Magorien RD; Unverferth DV; Brown GP; Leier CV
    J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):499-505. PubMed ID: 6826960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new inotropic drug, dobutamine.
    Huss P; Miller J; Unverferth DV; Leier CV
    Heart Lung; 1981; 10(1):121-6. PubMed ID: 6905822
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of sodium nitroprusside and dobutamine on the ventricular myocardium in patients with severe left cardiac insufficiency].
    Cyran J; Bolte HD
    Verh Dtsch Ges Inn Med; 1978; (84):683-6. PubMed ID: 742099
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.
    Klein NA; Siskind SJ; Frishman WH; Sonnenblick EH; LeJemtel TH
    Am J Cardiol; 1981 Jul; 48(1):170-5. PubMed ID: 7246440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.